{
    "symbol": "OCGN",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-06 20:56:05",
    "content": " Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations including among other things; the uncertainties inherent in research and development of our product candidates; risks to our business related to the ongoing COVID-19 pandemic; uncertainty regarding whether and when we will be able to submit a biologics license application for Covaxin to the FDA; and whether and when we will receive regulatory approvals for Covaxin in the U.S., Canada, or Mexico. Your line is open. Your line is open. Your line is open. Your line is open."
}